Elypta (private company)

See something wrong or missing? Let us know
Offices:Gothenburg, Stockholm
Business model:B2B

Elypta is a molecular diagnostic company focused on preventing cancer mortality by developing a liquid biopsy platform for detection and monitoring of the disease. The approach is based on measurement of 20 biomarkers and use of machine learning algorithms to generate a score against cancer-type specific signatures.

Investors: we tracked 8 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 27.65M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Elypta

Name Criteria
Germany Atai Life Sciences
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Biofidelity
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom LabGenius
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark MedTrace
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Muna Therapeutics
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Top